In indolent NHL... As our knowledge evolves, so should our approach Our understanding of indolent non-Hodgkin lymphoma (iNHL) has improved greatly. Celgene is committed to developing new approaches that address the underlying immune dysfunction contributing to the disease.1 Reference: 1. Yang ZZ, Ansell SM. The tumor microenvironment in follicular lymphoma. Clin Adv Hematol Oncol. 2012;10(12):810-818. Explore the Chemosaurus and learn more about immune dysfunction in iNHL at booth 1005. #Chemosaurus #ASH17 © 2017 Celgene Corporation 10/17 US-CELG170282